Course Overview
This course aims to provide knowledge and skills for patients on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
Biosimilars represent a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
As awareness and use of biosimilars increases globally, this course will provide information and guidance to support patient understanding of the effective and safe use of biosimilars in clinical settings.
The course will focus on enhancing knowledge and skills for patients and caregivers related to biosimilars.
The course will utilize a modular approach to provide content that is accessible and informative to all learners, and provide an introduction to biosimilar medications including what they are, regulatory processes, access, and discussing biosimilars with your healthcare provider.
This is an online self-directed course. There are no instructor-led activities.
More News
Image
Starting opioid agonist treatment after hospitalization for toxicity halves risk of repeat event
Shaleesa Ledlie’s PhD research demonstrates importance of strong care pathways to initiate treatment for people soon after opioid toxicity.
Read More
Image
Eight pharmacists recognized for outstanding mentoring
Student-nominated EPE Preceptors of the Year provide invaluable guidance and support during early experiential courses.
Read More
Image
CARD at school helps students win against needle fear
CARD system provides evidence-based tools to improve vaccination experience for students and injectors in school and university settings.
Read More